The graft-versus-lymphoma effect: clinical review and future opportunities

D O I：

10.1038/sj.bmt.1705008

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

Numerous lines of preclinical and clinical evidence support the existence of a graft- versus- leukemia effect, but less evidence supporting a comparable graft- versus- lymphoma effect exists. We review here current clinical data addressing the graft- versus- lymphoma effect, including comparisons of autologous, syngeneic, and allogeneic transplantation; responses to immunomodulation; and responses to nonmyeloablative stem cell transplantation. Despite several limitations of the data, we believe that there is sufficient evidence suggesting a significant graft-versus-lymphoma effect. In addition, we discuss approaches for clinical management of lymphoma patients, opportunities for mechanistic studies afforded by donor leukocyte infusions and nonmyeloablative transplantation, and suggestions for clinical studies to further de. ne the magnitude and applicability of the graft- versus- lymphoma effect.

引用

页码：1 / 17

页数：17

共 138 条

[1] Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation [J].

Adkins, D ;

Brown, R ;

Goodnough, LT ;

Khoury, H ;

Popovic, W ;

DiPersio, J .

BONE MARROW TRANSPLANTATION, 1998, 21 (01) :97-99

[2] Long-term results of blood and marrow transplantation for Hodgkin's lymphoma [J].

Akpek, G ;

Ambinder, RF ;

Piantadosi, S ;

Abrams, RA ;

Brodsky, RA ;

Vogelsang, GB ;

Zahurak, ML ;

Fuller, D ;

Miller, CB ;

Noga, SJ ;

Fuchs, E ;

Flinn, IW ;

O'Donnell, P ;

Seifter, EJ ;

Mann, RB ;

Jones, RJ .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (23) :4314-4321

[3] Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease [J].

Anderlini, P ;

Giralt, S ;

Andersson, B ;

Ueno, NT ;

Khouri, I ;

Acholonu, S ;

Cohen, A ;

Körbling, MJ ;

Manning, J ;

Romaguera, J ;

Sarris, A ;

Rodriguez, MA ;

Hagemeister, F ;

McLaughlin, P ;

Cabanillas, F ;

Champlin, RE .

BONE MARROW TRANSPLANTATION, 2000, 26 (06) :615-620

[4] Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+cell dose, GVHD and disease response [J].

Anderlini, P ;

Acholonu, SA ;

Okoroji, GJ ;

Andersson, BS ;

Couriel, DR ;

De Lima, MJ ;

Donato, ML ;

Khouri, IF ;

Giralt, SA ;

Ueno, NT ;

Champlin, RE .

BONE MARROW TRANSPLANTATION, 2004, 34 (06) :511-514

[5] Successful treatment with reduced-intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma [J].

Aoyama, Y ;

Yamamura, R ;

Shima, E ;

Nakamae, H ;

Makita, K ;

Kho, G ;

Ohta, K ;

Yamane, T ;

Takubo, T ;

Hino, M .

ANNALS OF HEMATOLOGY, 2003, 82 (06) :371-373

[6]

ATRA A, 2002, BONE MARROW TRANSPL, V29, P63

[7] Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy [J].

Ballen, KK ;

Becker, PS ;

Emmons, RVB ;

Fitzgerald, TJ ;

Hsieh, CC ;

Liu, Q ;

Heyes, C ;

Clark, Y ;

Levy, W ;

Lambert, JF ;

Chiafari, F ;

Szymanski, I ;

Rososhansky, S ;

Popovsky, MA ;

Stewart, FM ;

Quesenberry, PJ .

BLOOD, 2002, 100 (02) :442-450

[8]

BAR BMAM, 1993, J CLIN ONCOL, V11, P513

[9] TREATMENT OF MURINE LEUKAEMIA WITH X-RAYS AND HOMOLOGOUS BONE MARROW - PRELIMINARY COMMUNICATION [J].

BARNES, DWH ;

CORP, MJ ;

LOUTIT, JF ;

NEAL, FE .

BRITISH MEDICAL JOURNAL, 1956, 2 (SEP15) :626-627

[10] Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens [J].

Bellucci, R ;

Wu, CJ ;

Chiaretti, S ;

Weller, E ;

Davies, FE ;

Alyea, EP ;

Dranoff, G ;

Anderson, KC ;

Munshi, NC ;

Ritz, J .

BLOOD, 2004, 103 (02) :656-663

← 1 2 3 4 5 6 7 8 9 10 →